287840 Stock Chart & Stats
₩14480.00
₩630.00(4.55%)
―
--
Day’s Range― - ―
52-Week Range₩13,050.00 - ₩74,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)62.99K
Market Cap
₩208.05B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.59
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,021,960
10 Day Avg. Volume53,336
30 Day Avg. Volume62,986
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)₩1.47T
287840 FAQ
What was IntoCell, Inc.’s price range in the past 12 months?
IntoCell, Inc. lowest stock price was ₩13050.00 and its highest was ₩74900.00 in the past 12 months.
What is IntoCell, Inc.’s market cap?
IntoCell, Inc.’s market cap is ₩208.05B.
When is IntoCell, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were IntoCell, Inc.’s earnings last quarter?
IntoCell, Inc. released its earnings results on May 15, 2026. The company reported -₩267.057 earnings per share for the quarter, missing the consensus estimate of N/A by -₩267.057.
Is IntoCell, Inc. overvalued?
According to Wall Street analysts IntoCell, Inc.’s price is currently Undervalued.
Does IntoCell, Inc. pay dividends?
IntoCell, Inc. does not currently pay dividends.
What is IntoCell, Inc.’s EPS estimate?
IntoCell, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IntoCell, Inc. have?
IntoCell, Inc. has 15,021,960 shares outstanding.
What happened to IntoCell, Inc.’s price movement after its last earnings report?
IntoCell, Inc. reported an EPS of -₩267.057 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.204%.
Which hedge fund is a major shareholder of IntoCell, Inc.?
Currently, no hedge funds are holding shares in KR:287840
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MEDIPOST Co., Ltd.
―
ToolGen Incorporated
―
EuBiologics Co., Ltd.
―
SillaJen, Inc.
―
Curocell, Inc.
―